Titan Pharmaceuticals, Inc.

Navigate Titan Pharmaceuticals, Inc.

  • Home
  • About
    • Overview
    • Who We Are
    • IP Portfolio
    • Management Team
    • Board of Directors
    • Careers
  • Technology
  • Pipeline
    • Kappa Opioid Receptor Agonist
    • Nalmefene Implant
  • News
    • Overview
    • Press Releases
    • Events
    • Presentations
    • In the News
    • Publications
    • Posters
    • Media Resources
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact
  • Search
  • Twitter

Press Releases

  • Home
  • Investors
  • News / Events
  • Press Releases
Investors

Navigate Investors

  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Information
  • Stock Data
  • SEC Filings
  • Corporate Governance
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed

Press Releases

  • All News
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009

Titan In Discussions With Braeburn Regarding U.S. Probuphine® Commercialization

January 22, 2018

Titan Pharmaceuticals Partners With Molteni To Market Probuphine® In Europe

November 28, 2017

European Medicines Agency Accepts Titan Pharmaceuticals' Marketing Authorization Application For Probuphine®

November 27, 2017

Titan Pharmaceuticals Reports Third Quarter 2017 Financial Results

November 9, 2017

Titan Pharmaceuticals Schedules Conference Call To Review Third Quarter 2017 Financial Results

November 3, 2017

Titan Pharmaceuticals Presents Non-Clinical Data From Liothyronine (L-T3) Implant Studies

October 19, 2017

First Patient Treated With Titan Pharmaceuticals' Subdermal Implant For Parkinson's Disease

October 11, 2017

Titan Pharmaceuticals and Opiant Pharmaceuticals Collaborate to Explore a New Approach to Opioid Use Disorder Treatment

October 2, 2017

Titan Pharmaceuticals To Present At Cantor Fitzgerald Global Healthcare Conference

September 20, 2017

Titan Pharmaceuticals Receives FDA Clearance To Begin Clinical Study Of Parkinson's Disease Treatment

August 24, 2017

RSS
  • « Previous
  • 1...
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • ...24
  • Next »
© 2023 Titan Pharmaceuticals, Inc. All Rights Reserved.
Privacy Policy Titan FCOI Policy Disclaimer Sitemap Twitter